文献速递腹部MR

压缩MR弹性成像评估肝细胞癌微血管侵犯

MR elastography in patients with hepatocellular carcinoma: tumor stiffening during compression induced by respiration to assess microvascular invasion.
PubMed 文献 · Eur Radiol · 2026-02-01

本前瞻性研究纳入53例拟手术切除的肝细胞癌患者,采用压缩MR弹性成像测量肿瘤呼气与吸气状态下基础黏弹性参数及呼吸压缩诱导的肿瘤硬化斜率。结果显示,无微血管侵犯肿瘤的压缩硬化斜率显著高于有微血管侵犯者,压缩硬化斜率检测微血管侵犯的AUC为0.83。

要点

  • 压缩MR弹性成像的肿瘤硬化斜率可作为肝细胞癌微血管侵犯的无创影像标志物。
  • 肿瘤呼吸压缩硬化斜率低于无微血管侵犯肿瘤时,应提示微血管侵犯风险。
  • 基础黏弹性参数对肝细胞癌微血管侵犯的诊断价值有限。

核心结论

  • 压缩MR弹性成像的肿瘤压缩硬化斜率可用于诊断肝细胞癌患者的微血管侵犯。

研究设计与样本

  • 前瞻性术前MR弹性成像研究,纳入拟行手术切除的连续肝细胞癌患者53例,均有完整手术切除、MR弹性成像及组织病理学数据。
  • MR弹性成像评估的肿瘤参数包括呼气与吸气状态下的基础黏弹性参数(储能模量、损耗模量、相位角)及呼吸压缩诱导的肿瘤硬化斜率。
  • 以手术切除肿瘤的组织病理学检查确定微血管侵犯状态。

关键影像表现/征象

  • 无微血管侵犯肝细胞癌的呼吸压缩诱导肿瘤硬化斜率显著高于有微血管侵犯者(p < 0.001)。
  • 无微血管侵犯肝细胞癌吸气与呼气间储能模量差值高于有微血管侵犯者(p = 0.03)。
  • 在临床、形态学及生物力学影像特征中,MR弹性成像压缩硬化斜率是肝细胞癌微血管侵犯的独立决定因素(p = 0.004)。

诊断标准与关键数值

  • 压缩硬化斜率检测肝细胞癌微血管侵犯的AUC为0.83(p < 0.001)。
  • 组织学WHO分化程度是肝细胞癌微血管侵犯的独立决定因素(p = 0.02-0.03)。
  • 基础黏弹性参数对检测肝细胞癌微血管侵犯诊断效能不高,与压缩硬化斜率形成对比。

临床应用与阅片要点

  • 在日常报告中可报告MR弹性成像肿瘤压缩硬化斜率,以辅助判断肝细胞癌微血管侵犯风险。
  • 观察呼吸状态下肿瘤硬度变化时,需注意呼吸压缩幅度对硬化斜率测量的潜在影响。

局限性

  • 样本量为53例,其中31例存在微血管侵犯。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Microvascular invasion is a strong prognostic factor in hepatocellular carcinomas. The aim of our study was to assess the diagnostic value of mechanical parameters measured with compression MR elastography to detect microvascular invasion in hepatocellular carcinomas.

MATERIALS AND METHODS: In this prospective preoperative MR elastographic study, consecutive patients with hepatocellular carcinomas, scheduled for tumor surgical resection, were included. The tumor parameters assessed with MR elastography were the basal visco-elastic parameters (storage modulus, loss modulus, and phase angle, reflecting elasticity, viscosity and visco-elastic ratio) during expiration and inspiration, and the tumor stiffening slope during compression induced by respiration, reflecting non-linear elasticity. Microvascular invasion was determined with histopathological examination of resected tumors. Diagnostic performance of MR elastography was assessed with area under the receiver operating curve (AUC) analysis.

RESULTS: The final study group consisted of 53 patients with complete surgical resection, MR elastography and histological data, including 31 patients with microvascular invasion. Compression stiffening slope and storage modulus difference between inspiration and expiration were significantly higher in hepatocellular carcinomas without than with microvascular invasion (p < 0.001 and p = 0.03, respectively). Among clinical, morphological and biomechanical imaging features, the MR elastography compression stiffening slope (p = 0.004) and histological WHO differentiation (p = 0.02-0.03) were the only independent determinants of hepatocellular carcinoma microvascular invasion. In contrast to basal biomechanical parameters, the compression stiffening slope had high diagnostic performance for detecting microvascular invasion (AUCcompression stiffening = 0.83, p < 0.001).

CONCLUSION: Our results suggest that the compression stiffening slope at MR elastography is useful to diagnose microvascular invasion in patients with hepatocellular carcinomas.

KEY POINTS: Question Because non-invasive imaging markers of hepatocellular microvascular invasion are lacking, the development of new MRI markers is advisable. Findings In our MR elastography study, respiration-induced tumor stiffening, in contrast to basal visco-elastic parameters, had good accuracy for diagnosing hepatocellular carcinoma microvascular invasion. Clinical relevance Our results in patients with hepatocellular carcinomas suggest that the non-invasive measurement of MR elastography tumor compression stiffening slope may assess microvascular invasion.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Pagé, Garteiser, Paradis, et al. MR elastography in patients with hepatocellular carcinoma: tumor stiffening during compression induced by respiration to assess microvascular invasion. Eur Radiol. 2026. PMID: 41621038. doi:10.1007/s00330-025-12164-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。